Dapagliflozin Effect in Cognitive Impairment in Stroke Trial
Condition(s):Stroke, Ischemic; Mild Cognitive Impairment; Dementia, Vascular; Metabolic SyndromeLast Updated:October 4, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Stroke, Ischemic; Mild Cognitive Impairment; Dementia, Vascular; Metabolic SyndromeLast Updated:October 4, 2022Recruiting
Condition(s):StrokeLast Updated:January 25, 2012Unknown status
Condition(s):Intracerebral Hemorrhage; StatinsLast Updated:January 23, 2024Recruiting
Condition(s):HypercholesterolaemiaLast Updated:September 9, 2019Completed
Condition(s):Cardiovascular DiseaseLast Updated:March 30, 2012Withdrawn
Condition(s):Obstructive Coronary Artery Disease; Coronary Artery DiseaseLast Updated:February 13, 2018Completed
Condition(s):Chronic PeriodontitisLast Updated:June 29, 2017Completed
Condition(s):AtherosclerosisLast Updated:August 8, 2016Completed
Condition(s):Hypertriglyceridemia (TG>200<500); Hyperlipidemia; Coronary Artery Disease; Coronary Risk Equivalent; DiabetesLast Updated:November 18, 2011Completed
Condition(s):HepatopathyLast Updated:April 20, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.